These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16252380)

  • 1. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression".
    Taragano FE; Bagnatti P; Allegri RF
    Int Psychogeriatr; 2005 Sep; 17(3):487-98. PubMed ID: 16252380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'.
    Taragano FE; Allegri R; Vicario A; Bagnatti P; Lyketsos CG
    Int J Geriatr Psychiatry; 2001 Mar; 16(3):254-60. PubMed ID: 11288158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
    Rudolph RL; Feiger AD
    J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M; Vandoolaeghe E; Desnyder R
    J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
    Holland JC; Romano SJ; Heiligenstein JH; Tepner RG; Wilson MG
    Psychooncology; 1998; 7(4):291-300. PubMed ID: 9741068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
    Keller MB; Trivedi MH; Thase ME; Shelton RC; Kornstein SG; Nemeroff CB; Friedman ES; Gelenberg AJ; Kocsis JH; Dunner DL; Hirschfeld RM; Rothschild AJ; Ferguson JM; Schatzberg AF; Zajecka JM; Pedersen RD; Yan B; Ahmed S; Musgnung J; Ninan PT
    J Clin Psychiatry; 2007 Aug; 68(8):1246-56. PubMed ID: 17854250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
    Katona CL; Abou-Saleh MT; Harrison DA; Nairac BA; Edwards DR; Lock T; Burns RA; Robertson MM
    Br J Psychiatry; 1995 Jan; 166(1):80-6. PubMed ID: 7894881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.
    Pazzaglia PJ; Post RM; Ketter TA; Callahan AM; Marangell LB; Frye MA; George MS; Kimbrell TA; Leverich GS; Cora-Locatelli G; Luckenbaugh D
    J Clin Psychopharmacol; 1998 Oct; 18(5):404-13. PubMed ID: 9790159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone.
    Onder E; Tural U
    J Affect Disord; 2003 Sep; 76(1-3):223-7. PubMed ID: 12943952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
    Silverstone PH; Ravindran A
    J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response.
    Ryszewska-Pokraśniewicz B; Mach A; Skalski M; Januszko P; Wawrzyniak ZM; Poleszak E; Nowak G; Pilc A; Radziwoń-Zaleska M
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30081500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine in the prevention of depressive recurrences: a double-blind study.
    Gilaberte I; Montejo AL; de la Gandara J; Perez-Sola V; Bernardo M; Massana J; Martin-Santos R; Santiso A; Noguera R; Casais L; Perez-Camo V; Arias M; Judge R;
    J Clin Psychopharmacol; 2001 Aug; 21(4):417-24. PubMed ID: 11476126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
    Smith WT; Londborg PD; Glaudin V; Painter JR;
    J Affect Disord; 2002 Aug; 70(3):251-9. PubMed ID: 12128237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly dosing of fluoxetine for the continuation phase of treatment of major depression: results of a placebo-controlled, randomized clinical trial.
    Burke WJ; Hendricks SE; McArthur-Miller D; Jacques D; Bessette D; McKillup T; Stull T; Wilson J
    J Clin Psychopharmacol; 2000 Aug; 20(4):423-7. PubMed ID: 10917403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response.
    Sanacora G; Berman RM; Cappiello A; Oren DA; Kugaya A; Liu N; Gueorguieva R; Fasula D; Charney DS
    Neuropsychopharmacology; 2004 Jun; 29(6):1166-71. PubMed ID: 15010697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.